Inventor · disambiguated record
Thao Perry
Also filed as: PERRY THAO · PERRY THAO D
47 granted patents·11 pending applications·786 citations·filing 1998–2023
98Inventor score
Files withGILEAD SCIENCES INC22CV THERAPEUTICS INC10PHARMACIA CORP4SEARLE & CO4CORKEY BRITTON KENNETH3
Top patents by PatentIndex Score
58 records- 0197US11939347B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Mar 26, 2024·7 cites·45 claims
- 0296US6979686B1Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2001·Granted Dec 27, 2005·64 cites·63 claims
- 0396US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0496US6423713B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2001·Granted Jul 23, 2002·90 cites·88 claims
- 0595US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 0695US6525059B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2000·Granted Feb 25, 2003·62 cites·79 claims
- 0794US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0894US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0994US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 1094US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 1193US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 1293US7741331B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 22, 2010·16 cites·8 claims
- 1393US6617324B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 2002·Granted Sep 9, 2003·47 cites·112 claims
- 1492US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 1591US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 1691US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 1790US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 1890US7795269B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Sep 14, 2010·8 cites·14 claims
- 1990US6514977B1Substituted pyrazoles as p38 kinase inhibitorsSEARLE & CO·Filed 1998·Granted Feb 4, 2003·70 cites·92 claims
- 2089US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 2189US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 2289US8389500B2Fused heterocyclic compounds as ion channel modulatorsABELMAN MATTHEW·Filed 2009·Granted Mar 5, 2013·16 cites·24 claims
- 2388US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 2486US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 2584US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 2684US8324224B2A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Dec 4, 2012·5 cites·8 claims
- 2783US8158810B2ALDH-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2009·Granted Apr 17, 2012·7 cites·11 claims
- 2882US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 2982US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 3081US12404289B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 3181US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 3281US7381714B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 3, 2008·4 cites·22 claims
- 3380US7105665B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 12, 2006·12 cites·33 claims
- 3479US7071198B1Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2004·Granted Jul 4, 2006·7 cites·7 claims
- 3578US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
- 3677US7514417B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 7, 2009·2 cites·23 claims
- 3776US7153959B2Substituted pyrazoles as p38 kinase inhibitorsPHARMACIA CORP·Filed 2003·Granted Dec 26, 2006·6 cites·9 claims
- 3874US7696181B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted Apr 13, 2010·1 cites·23 claims
- 3973US7144871B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2003·Granted Dec 5, 2006·5 cites·15 claims
- 4072US7449473B2Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Nov 11, 2008·5 cites·16 claims
- 4170US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 4263US11229638B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jan 25, 2022·0 cites·7 claims
- 4363US2009325896A1Partial and full agonists of a1 adenosine receptorsIBRAHIM PRABHA·Filed 2009·Application pending·0 cites
- 4462US2013123280A1A2b adenosine receptor antagonistsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 4560US2009156544A1A1 adenosine receptor agonistsELZEIN ELFATIH·Filed 2009·Application pending·0 cites
- 4658US2011130362A1A2b adenosine receptor antagonistsGILEAD SCIENCES INC·Filed 2011·Application pending·0 cites
- 4756US2010222300A1A2B Adenosine Receptor AntagonistsGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 4851US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 4951US2008318983A1A2b adenosine receptor antagonistsKALLA RAO·Filed 2008·Application pending·0 cites
- 5050US2004127492A1Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2PHARMACIA CORP·Filed 2003·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →